As the COVID-19 vaccine becomes more readily available, a conversation between you and your clinical team may assist with decisions regarding the use of vaccines approved under EUA for the prevention of COVID-19 by pregnant patients. Important considerations include:
- the level of activity of the virus in the community
- the potential efficacy of the vaccine
- the risk and potential severity of maternal disease, including the effects of disease on the fetus and newborn
- the safety of the vaccine for the pregnant patient and the fetus.
For the most up-to-date information and resources visit The American College American College of Obstetricians and Gynecologists here.
Meet our Doctors & Nurse Practitioners
Dina M. Canavero,MD, MPH, FACOG
Jacqueline Ho,MD, FACOG
Blake R. Lambourne,MD, FACOG
David H. Scates,MD, FACOG
Denise L. Sweeney,MD, FACOG
Richard J. Leach,MD, FACOG
Analisa Marki-Dunn,MD, FACOG
Catherine E. Taylor,NP
Allison Della Maggiora,RN, MSN, FNP-C